(Boursier.com) — The Annual General Meeting of Gour Medical was held on June 29 at 10 a.m. in Paris. The shareholders present or represented held 81.11% of the shares and voting rights.
All the proposed resolutions were approved unanimously, with the exception of the delegation of authority to be given to the Board of Directors to increase the company’s capital for the benefit of members of the company savings plan.
On the other hand, the meeting approved the losses of 164,176.60 euros for the financial year ended December 31, 2021 and of 56,144.40 euros for the financial year ended December 31, 2022 and their allocation to the “Retained earnings” account.
The assembly also:
– decided to appoint Jean Descaves as a member of the Board of Directors until the end of the general meeting called to approve the financial statements for the year ended December 31, 2028;
– noted the resignation of Loïc Maurel and the company Gilles Avenard Biotech Consulting from their functions as members of the board of directors.
New corporate purpose
The Meeting modified the corporate purpose, which will now be:
– the acquisition of interests and holdings in any French or foreign company or enterprise by any means, and in particular by way of merger or acquisition,
– the acquisition, sale, administration and operation of all buildings,
– the provision of services, advice and assistance, in particular financial, to companies,
– the granting of sureties, endorsements and guarantees in order to facilitate the financing of subsidiaries, companies or organizations in which the company holds a stake or an interest,
– and more generally, all commercial, financial, industrial, securities or real estate transactions that may be directly or indirectly related to the corporate purpose and to any similar or related purposes.
The Assembly amended the corporate name who will now be Coretech 5.
To the Board of Directors
It has delegated its authority to the Board of Directors to reduce the capital by reducing the par value of the shares.
The Board of Directors of Coretech 5 is therefore composed, at the end of the general meeting, of the following 3 members: Serge Goldner (chairman); Christian Grandjean; Jean Descaves.